Skip to main content
Caplight Logo









DeepCyte

DeepCyte

Private
Wilmington, DelawareHealthcare & Life Scienceshttps://www.deepcyte.bio/

Last Round

Seed

Apr 9, 2026

Total Funding Raised

$1.5M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

DeepCyte is a techbio company that combines single-cell metabolomics with AI models to detect and predict drug toxicity early for the biopharma industry.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

toxicologydrug discoverysingle-cell metabolomicstechbiopredictive toxicologyin silico toxicologypreclinical safetyAI drug discoverymechanistic analysisdrug safetycomputational biologyclinical trial failurehigh-throughput screeningdata as a serviceDaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DeepCyte Comparables

Compare DeepCyte with similar companies based on industry and business-model similarity.

DeepCyte comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Axiom Bio
87%
Ignota Labs
79%
VeriSIM Life
74%

DeepCyte Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 9, 2026

Key People

Founding team and executive leadership

Theodore Alexandrov

CEO & co-founder

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 12, 2026

    Grew 75% QoQ from 4 to 7 employees.

  • Apr 9, 2026

    $2M raised in Seed round.

DeepCyte Filings

Explore SEC and related filing metadata, where available.

DeepCyte filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about DeepCyte's valuation, stock price, and market status.

Is DeepCyte a public or private company?

DeepCyte is a private company.

What is the current stock price of DeepCyte?

DeepCyte is a private company with no public stock price. No recent secondary market data is available.

How much is DeepCyte worth (valuation)?

Valuation information for DeepCyte is not publicly available.

Can I buy DeepCyte stock?

DeepCyte shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was DeepCyte's last funding round?

DeepCyte's most recent funding round was Seed on April 9, 2026.

Who are the main investors in DeepCyte?

Investor information for DeepCyte is not publicly disclosed.

Will DeepCyte IPO soon?

No public IPO plans have been announced for DeepCyte.

How can I track DeepCyte secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor DeepCyte's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWilmington, Delaware
Employee Range9
Year Founded2024
Last FundingApr 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?